Thursday, February 18, 2010
Single microRNA exhibits potential to forecast outcomes of MPM (News-Medical-Net)
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announced today that the results of a joint study with the NYU Langone Medical Center were published online on February 16th, 2010, and are set to be published in the March 1st issue of the American Association for Cancer Researchâs journal, Cancer Research.
Return to Mesothelioma Search Blog Home Page mesothelioma
